1. Home
  2. ALPS vs ELOX Comparison

ALPS vs ELOX Comparison

Compare ALPS & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ALPS Group Inc Ordinary Share

ALPS

ALPS Group Inc Ordinary Share

N/A

Current Price

$0.32

Market Cap

66.6M

Sector

N/A

ML Signal

N/A

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$12.87

Market Cap

60.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ALPS
ELOX
Founded
2017
1999
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
66.6M
60.3M
IPO Year
2024
2013

Fundamental Metrics

Financial Performance
Metric
ALPS
ELOX
Price
$0.32
$12.87
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $37.50
AVG Volume (30 Days)
★ 31.0K
21.5K
Earning Date
07-24-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 41.67
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.23
$10.00
52 Week High
$1.72
$23.40

Technical Indicators

Market Signals
Indicator
ALPS
ELOX
Relative Strength Index (RSI) 28.57 42.34
Support Level $0.23 $10.74
Resistance Level $0.42 $14.65
Average True Range (ATR) 0.01 1.10
MACD -0.00 0.11
Stochastic Oscillator 10.90 45.09

Price Performance

Historical Comparison
ALPS
ELOX

About ALPS ALPS Group Inc Ordinary Share

ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: